Loading
Loading
Verified employee & interview reviews
Bengaluru, Karnataka
Indegene Limited is an Indian tech-native, digital-first life sciences commercialization company that provides research, analytics, technology, and commercialization services to healthcare enterprises. Founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr. Sanjay Parikh, and Anand Kiran, the company is headquartered in Bengaluru, India. It maintains a global operations footprint with offices across the United States, Europe, and the Asia-Pacific region, assisting biopharmaceutical, emerging biotech, and medical device companies to efficiently develop, launch, and scale up products within the international marketplace. The company operates through three major core business segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. In the Enterprise Medical Solutions vertical, Indegene assists organizations with regulatory compliance, market access strategy, content creation, medical information management, and safety/pharmacovigilance operations. The Enterprise Commercial Solutions segment specializes in driving digital transformations, accelerating go-to-market strategies, and optimizing the structural efficiency of commercial campaigns. Through its Omnichannel Activation models and the proprietary NEXT technology platform, Indegene enables scalable, secure, and data-driven engagement, unifying the content value chain to deliver personalized experiences for patients and physicians. Financially, Indegene transitioned from a private entity to a publicly traded corporation following its initial public offering (IPO) in May 2024, which raised INR 1,842 crore. The company's equity shares are actively traded on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) under the ticker symbols INDGN and 544172, respectively. For the fiscal year ending March 31, 2026, Indegene reported a consolidated annual revenue of approximately INR 3,580 crore ($406 million), operating with a market capitalization valued around INR 12,491 crore. Significant institutional backing has historically been provided by major private equity entities, including the Carlyle Group and Brighton Park Capital. The executive leadership team is directed by Co-Founder, Executive Chairman, and CEO Manish Gupta, alongside Executive Director and Executive VP Dr. Sanjay Suresh Parikh and CFO Suhas Prabhu. Managing a global workforce of over 5,000 employees, Indegene utilizes deep healthcare domain expertise alongside advanced technology frameworks, including artificial intelligence and machine learning solutions under its "Cortex" program, to streamline complex clinical and commercial operations. The enterprise serves a highly elite client portfolio, counting 20 of the world’s top 20 biopharmaceutical organizations among its partners, and continues to expand its market share through targeted strategic acquisitions such as MedCases, Aptilon, DT Associates, and BioPharm.
No reviews yet for Indegene. Be the first to share your workplace experience on Rewyoo.